More info
Novel Brigatinib PROTAC degrader, degrading not only ALK fusion proteins in activating G1202R-mutated form but also mutant EGFR with L858R + T790M as well as several important oncoproteins involved in metastasis such as FAK, PYK2, and PTK6, strongly inhibiting cell migration and invasion of Calu-1 and MDA-MB-231